Kazia Therapeutics to Present at HC Wainwright 23rd Annual Global Investment Conference
- Written by PR Newswire
 |
SYDNEY, Sept. 11, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, Dr James Garner, will be presenting at the HC Wainwright 23rd Annual Global Investment Conference, to be held virtually from 13-15 September 2021.
The HC Wainwright Annual Global...
